SuspendedNot Applicable

Advanced Development of Desorption Electrospray Ionization Mass Spectrometry for Intraoperative Molecular Diagnosis of Brain Cancer Using Pathology Biopsies

Stopped: Funding issues

United States285 participantsStarted 2020-10-26

Plain-language summary

This study explores whether DESI-MS can be used to identify cancerous vs. noncancerous tissue during brain tumor surgery.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male and female patients age 18 and older * Patients or their legally authorized representative (LAR) able to provide written consent * Schedule to undergo tumor resection Exclusion Criteria: * Pregnant women

What they're measuring

Pathological state of the tissue

Timeframe: Up to 5 years

Percentage of tumor infiltration

Timeframe: Up to 5 years

Presence of IDH mutations

Timeframe: Up to 5 years

Trial details

NCT IDNCT06387979

SponsorMayo Clinic

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-10-15

View on ClinicalTrials.gov More Glioma trials